Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipid abnormalities.

Michael Dube1, Marcy Fenton

  • 1Indiana University School of Medicine, Wishard Memorial Hospital, Division of Infectious Diseases, Indianapolis, Indiana 46202-2879 , USA. mpdube@iupui.edu

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|March 26, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Full Return to Sport in All Athletes After Suture-Button Fixation for Syndesmotic Injuries; However, Faster Recovery Was Seen in National Collegiate Athletic Association Football Players Compared with National Football League Players.

Arthroscopy, sports medicine, and rehabilitation·2026
Same author

Athletic Performance at the National Football League Scouting Combine After Arthroscopic Meniscal Surgery.

Orthopaedic journal of sports medicine·2025
Same author

Effects of Tesamorelin on Neurocognitive Impairment in Persons With HIV and Abdominal Obesity.

The Journal of infectious diseases·2025
Same author

Preoperative Fascia Iliaca Blocks Associated With Decreased Opioid Consumption in Femoral Shaft and Distal Femur Fractures.

Journal of orthopaedic trauma·2024
Same author

All lockdowns are not equal: Reducing epidemic impact through evolutionary computation.

Bio Systems·2023
Same author

What are patients asking and reading online? An analysis of online patient searches for rotator cuff repair.

Journal of shoulder and elbow surgery·2023

Dyslipidemia is a significant issue for individuals with human immunodeficiency virus (HIV) on antiretroviral therapy, increasing cardiovascular disease risk. Management should follow guidelines, prioritizing lifestyle changes before medication to minimize drug interactions.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Dyslipidemia presents a major clinical challenge in patients with human immunodeficiency virus (HIV) undergoing antiretroviral therapy (ART).
  • Increased incidence of cardiovascular disease (CVD) is reported in the HIV-infected population on ART.
  • Current evidence highlights the need for proactive management of lipid disorders in this demographic.

Purpose of the Study:

  • To outline the clinical approach to managing dyslipidemia in HIV-infected individuals on ART.
  • To emphasize the importance of adhering to established guidelines for cardiovascular risk assessment and treatment.
  • To guide the selection of therapeutic interventions, prioritizing safety and minimizing drug interactions.

Main Methods:

  • Evaluation and treatment strategies should align with the National Cholesterol Education Program (NCEP) guidelines.

Related Experiment Videos

  • Nonpharmacological interventions, including dietary modifications, exercise, and management of other lifestyle risk factors, should be the primary approach.
  • Pharmacological therapy should be considered only when nonpharmacological methods are insufficient, with careful selection of agents to avoid adverse drug interactions.

    • Main Results:

    • Adherence to NCEP guidelines provides a structured framework for managing dyslipidemia in HIV patients.
    • Lifestyle modifications are effective initial strategies for improving lipid profiles.
    • The choice of lipid-lowering medications requires careful consideration of potential interactions with antiretroviral drugs.

    Conclusions:

    • Dyslipidemia management in HIV-infected individuals on ART is crucial for reducing cardiovascular risk.
    • A stepwise approach, starting with lifestyle changes, is recommended.
    • Pharmacological interventions should be chosen judiciously to ensure safety and efficacy, minimizing drug-drug interactions.